NCT04484480

Brief Summary

Diabetes mellitus type II (DMII) causes many complications, including retinopathy and peripheral neuropathy. These complications are well understood and believed to contribute to gait instability and increase the risk of falls. Poor balance control and increased falling risk have also been reported in people with diabetic peripheral neuropathy (DPN). Patients with DPN are at an increased risk of falling due to the decreased proprioceptive feedbacks. Effective balance training should improve instabilities of postural control in patients with DPN. For this purpose, evaluations and balance training was designed. The goal of our study was to establish values for proprioception, balance, muscle coordination and strength in patients with DMII, who underwent biofeedback balance training using the Biodex Balance System.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
77

participants targeted

Target at P25-P50 for not_applicable diabetes-mellitus-type-2

Timeline
Completed

Started Jan 2020

Shorter than P25 for not_applicable diabetes-mellitus-type-2

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2020

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2020

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

July 20, 2020

Completed
3 days until next milestone

First Posted

Study publicly available on registry

July 23, 2020

Completed
Last Updated

July 29, 2020

Status Verified

July 1, 2020

Enrollment Period

3 months

First QC Date

July 20, 2020

Last Update Submit

July 28, 2020

Conditions

Keywords

diabetesgaitbalancefalls

Outcome Measures

Primary Outcomes (4)

  • Fall risk test

    Test performed with use of Biodex platform to measure participant's ability to maintain the center of gravity on an unstable substrate in three 20-second trials. The lower the values of the fall index were, the better the result.

    3-months after inclusion to the study

  • General Stability Index

    Test performed with use of Biodex platform to measure participant's ability to maintain the center of gravity on an unstable substrate in three 20-second trials

    3-months after inclusion to the study

  • Frontal-Posterior Stability Index)

    Test performed with use of Biodex platform to measure participant's ability to maintain the center of gravity on an unstable substrate in three 20-second trials

    3-months after inclusion to the study

  • Medial-Lateral Stability Index

    Test performed with use of Biodex platform to measure participant's ability to maintain the center of gravity on an unstable substrate in three 20-second trials

    3-months after inclusion to the study

Study Arms (2)

Balance training

EXPERIMENTAL

Patients included in the study group, who received 3-month proprioception, balance and motor coordination training using the dynamic platform - Biodex Balance System.

Procedure: Balance training

Control group

NO INTERVENTION

Patients included in the control group who did not received any intervention

Interventions

Proprioception, balance and motor coordination training using the dynamic platform - Biodex Balance System.

Balance training

Eligibility Criteria

Age65 Years+
Sexall
Healthy VolunteersNo
Age GroupsOlder Adult (65+)

You may qualify if:

  • willingness to participate in the study
  • age over 65
  • diagnosed type 2 diabetes, subjected to pharmacological treatment (study group)
  • no type 2 diabetes (control group)

You may not qualify if:

  • unwillingness to participate in the study
  • age below 65 years
  • surgical intervention in the lower limbs or spine during the last 6 months
  • symptoms of osteoarthritis or pain of another origin around the lower limbs or spine
  • rheumatic diseases (eg. rheumatoid arthritis, ankylosing spondylitis)
  • diagnosed neuromuscular disease
  • strongly manifested imbalances due to impairment of central or peripheral nervous system
  • neurological disorders with dizziness, nystagmus, dermatologic or profound (cerebrospinal syndrome, dizziness, multiple sclerosis, Parkinson's disease, etc.).

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Department of Othopedics and Rehabilitation, Medical University of Warsaw

Warsaw, Masovian Voivodeship, 03-984, Poland

Location

Related Publications (2)

  • Adamska O, Mamcarz A, Lapinski M, Radzimowski K, Stepinski P, Szymczak J, Swiercz M, Zarnovsky K, Maciag BM, Stolarczyk A. Continuous glycemia monitoring in perioperative period in patients undergoing total knee or hip arthroplasty: A protocol for a prospective observational study. Medicine (Baltimore). 2022 Oct 21;101(42):e31107. doi: 10.1097/MD.0000000000031193.

  • Stolarczyk A, Jarzemski I, Maciag BM, Radzimowski K, Swiercz M, Stolarczyk M. Balance and motion coordination parameters can be improved in patients with type 2 diabetes with physical balance training: non-randomized controlled trial. BMC Endocr Disord. 2021 Jul 3;21(1):143. doi: 10.1186/s12902-021-00804-8.

MeSH Terms

Conditions

Diabetes Mellitus, Type 2Gait Disorders, NeurologicDiabetes Mellitus

Condition Hierarchy (Ancestors)

Glucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System DiseasesNeurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Artur Stolarczyk, MD, PhD

    Medical University of Warsaw

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
INVESTIGATOR, OUTCOMES ASSESSOR
Masking Details
Investigator an outcomes assessor were blinded for the information whether analyzed participant was in the interventional group or control one.
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 20, 2020

First Posted

July 23, 2020

Study Start

January 1, 2020

Primary Completion

April 1, 2020

Study Completion

April 1, 2020

Last Updated

July 29, 2020

Record last verified: 2020-07

Data Sharing

IPD Sharing
Will share

The datasets used during the current study are not publicly available because of patient integrity but are available from the corresponding author on reasonable request

Shared Documents
STUDY PROTOCOL, SAP
Time Frame
Data will be available on reasonable request for 36 months

Locations